GRAMD2B
GRAM domain-containing protein 2B
Also known as: FLJ21313, GRAMD3, GRM2B_HUMAN, NS3TP2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96HH9
- Gene
- GRAMD2B
- Ensembl
- ENSG00000155324
- Chromosome
- 5
- Canonical length
- 432 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
OverviewNCBI Gene
Enables identical protein binding activity. Located in cytoplasmic microtubule. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
432 residues, UniProt reviewed canonical sequence.
>Q96HH9|GRAMD2B
1 MTELQQDVED TKPAKVLGKR ESKLGSAHSE AENGVEEKKK ACRSPTAQSP TPSVEADSPD
61 QKKIISLWSK SSFDGASLAS DKNDCKTESK NDPKTERKKS SSSSQYKANM HFHKLFLSVP
121 TEEPLKQSFT CALQKEILYQ GKLFVSENWI CFHSKVFGKD TKISIPAFSV TLIKKTKTAL
181 LVPNALIIAT VTDRYIFVSL LSRDSTYKLL KSVCGHLENT SVGNSPNPSS AENSFRADRP
241 SSLPLDFNDE FSDLDGVVQQ RRQDMEGYSS SGSQTPESEN SRDFHATESQ TVLNVSKGEA
301 KPTRADAHVN RVPEGKAKSL PVQGLSETVG ILHKVKSQKC PMLHHILIFY AIVVCALIIS
361 TFYMRYRINT LEEQLGLLTS IVDTHNTEQA APSGLRSQVQ FNVEVLCQEL TANIVKLEKI
421 QNNLQKLLEN GDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRAMD2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 63 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 63 nTPM
- basal ganglia: 45 nTPM
- amygdala: 44 nTPM
- thyroid gland: 38 nTPM
- breast: 36 nTPM
- cerebral cortex: 36 nTPM
Single-cell type
- endometrial glandular cells: 902 nCPM
- astrocytes: 657 nCPM
- ependymal cells: 630 nCPM
- epididymal basal cells: 373 nCPM
- enterocytes: 361 nCPM
- retinal pigment epithelial cells: 358 nCPM
Immune cell
- plasmacytoid DC: 4.3 nTPM
- naive CD4 T-cell: 3 nTPM
- gdT-cell: 2.9 nTPM
- MAIT T-cell: 2.9 nTPM
- T-reg: 2.4 nTPM
- memory CD8 T-cell: 2.3 nTPM
Brain region
- spinal cord: 103 nTPM
- midbrain: 103 nTPM
- medulla oblongata: 96 nTPM
- white matter: 90 nTPM
- basal ganglia: 84 nTPM
- amygdala: 84 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GRAM domain
- PH-like domain superfamily
- GRAM domain
- GRAM domain-containing protein 2B
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRAMD2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRAMD2B as an antibody target. Whether an autoantibody or antibody against GRAMD2B could matter depends on whether native GRAMD2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRAMD2B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GRAMD2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...